in the general population. Furthermore, other findings support the role of childhood trauma as a socio-environmental risk factor for psychotic symptoms, and research on the potential etiological relationship between trauma/stressful events in childhood/adolescence and psychotic disorders is evolving. The aim of the current study was to examine relations among all items and domains of childhood trauma and schizophrenic symptoms in patients with schizophrenia. The relationship between types of trauma and their association with psychotic symptoms was analysed. Methods: In this study, we collected data from 50 schizophrenic patients (39 males and 11 females). All patients met the DSM 5 criteria for schizophrenia. Psychotic symptoms were measured by the Positive and Negative Syndrome Scale (PANSS). Trauma and stressful events in childhood and adolescence were assessed using the Childhood Trauma Questionnaire (CTQ). Results: We found significant correlations between emotional and sexual abuse, emotional neglect and denial scale in CTQ with positive symptoms of the PANSS (p<0,05). Meanwhile, no correlations were found between CTQ domains neither with negative symptoms nor with general psychopathology scale of the PANSS. Discussion: This study showed that childhood trauma could be a predictor factor for developing positive symptoms in schizophrenia. Most studies found similar results, showing a correlation between childhood trauma and hallucinations in schizophrenia. A correlation between childhood trauma and agressive behaviours was also described in litterature. These results went along with the stress sensitization model where the HPA axis is overactive and excessively reactive to the subsequent environemental stressors causing positive symptoms of the disease.
Background: Developments in electronic health (e-Health) interventions for psychotic patients have been possible since the growing access and use of internet and electronic devices in past 10 years (Bonet et al. 2017) . However, before proceeding further on develop these interventions; limited knowledge exists about the impact of internet and new technologies on the mental health of these psychotic patients. The aim of this study is to assess the benefits and risks of new technologies usage in a survey of patients diagnosed with psychotic disorders. We analyzed the relationship between experiences and opinions about internet and demographic and clinical characteristics of the sample and patterns of use of these technologies. Methods: Structured questionnaire was designed. This questionnaire was divided in three parts: 1) clinical and demographic information, 2) access and use of technologies, and 3) experiences and opinions about internet. In total, 97 patients diagnosed with psychotic disorder participated in this cross-sectional study. Mean age of the sample was 37.06 (SD=12.9), 72.2% of participants were male, 84.5% were single and 60.8% had achieved secondary education. Main diagnoses in the sample were First Episode of Psychosis (45.4%) and Schizophrenia (34%) and 64.9% of patients had a length of illness lower than 72 months Results: The percentage of patients who daily acceded to internet was 63.9% while 21.6% weekly acceded. 90.7% of participants owned a mobile phone and 68% had a social media account. Related to feelings about internet, 60.8% of patients felt socially linked due to internet usage and 78.4% felt informed. However, 22.7% felt frustrated and 19.6% felt suspicious. Internet was considered as a benefit for mental health for 46.4% of patients, while 38.1% have had unpleasant experiences related to its usage, 24.7% have had internet-related relapses and 26.8% expended excessive time online. Significant association was found between feeling informed and frequency of access to internet (χ2= 6.17 p=0.05), however any other significant association was found between feelings about internet and clinical or demographic characteristics or patterns of use of technology. According to experiences, significant associations were found between internet-related relapses and length of illness (χ2= 4.74 p=0.03), frequency of internet access (χ2= 9.76 p<0.01) and social media ownership (χ2= 5.55 p=0.02). Expending excessive time on internet was found significant associated to age of the sample (χ2= 6.57 p=0.04), employment status (χ2= 10.73 p=0.03), frequency of access to internet (χ2= 10.15 p<0.01) and social media ownership (χ2= 9.62 p<0.01). Association between stop taking medication because of information read on the internet and level of education was also found (χ2= 9.03 p=0.01). Discussion: Despite the general positive feelings about internet usage, percentages between 38-19% of patients had a negative vision of internet. Furthermore, frequency of access to internet and social media ownership have been found associated to internet-related relapses and potential pathological use of internet (excessive time on it). Younger patients, recent diagnosis of psychosis and being in a non-active employment situation seem to be related to these pathological results too. To our knowledge, this is the first study to describe the potential risks about internet usage in patients diagnosed with psychotic disorders, however further studies are needed. Reference: 
Center for Neuropsychiatric Schizophrenia Research, CNSR, and Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research, CINS, Mental Health Centre Glostrup, University of Copenhagen
Background: It is common knowledge that antipsychotic treatment improves the symptomatology in schizophrenia, especially for the psychotic and general symptoms. It is also a fact that patients with schizophrenia often report a reduced quality of life compared to healthy controls. In this study we aim at examining the relation between self-reported quality of life (QLS), psychopathological symptoms and level of function before and after antipsychotic treatment. We hypothesize that there will be a correlation between QLS and severity of symptoms before treatment. Further we expect an improvement in QLS after treatment and that this improvement will correlate with improvement in symptomatology. Methods: As a part of a large multimodal study on antipsychotic naïve patients with schizophrenia, 69 patients were recruited. Their psychopathology was measured with the Positive and Negative Syndrome Scale (PANSS), level of function was estimated using Global Assessment of Function (GAF), and QLS was reported by answering a questionnaire. Patients were treated with individual doses of Amisulpride for six weeks, after which they were reexamined. The questionnaire regarding QLS counts 21 questions, divided into four domains: Self and present life (i.e. "how satisfied are you with your present life"), social relations ("how satisfied are you with your current social life"), Living situation ("how much do you like the place you live") and Work situation ("How satisfied are you with the work you do"). Higher scores indicate higher satisfaction within the domain. Since the follow up period was only 6 weeks, we focused on self and present life (SPL) and social relations (SR), as we did not expect the living and work situation to change significantly within this period. Results: Baseline data were available on 48 patients, mean age 25 years (6.1), 31 males (65%). Their PANSS total score was 84 (16.0), GAF was 41(9.4), SPL-score was 13 (5.3) SR-score 10(5.3). For SPL as well as SR, there was a negative correlation with PANSS-total, PANSS-negative and PANSS-general (p-values<0.007). Follow-up data were available on 33 patients, mean age 25 years (6.6), 19 males (58%). They received 273 (163.3) mg Amisuplride. PANSS total was 68 (14.4) and GAF was 53 (15.7), SPL-score was 14 (3.9) SR-score 11(4.6). Paired T-test showed a significant improvement in PANSS total, PANSS positive, PANSS general and GAF (all p-values<0.001). There was also an improvement in SR (p=0.003), but no significant improvement in SPL and PANSS negative score (p=0.12 and p=0.5). There were no correlations between neither of the QLS scores and any psychopathology scores at follow up. Likewise, there was no correlation between change in QLS scores and change in psychopathology. However, there was a negative correlation with change in SPL and medication dose (p=0.009) Discussion: In this study, we found that antipsychotic naïve patients with most severe symptoms had the lowest self-reported QLS. This relation was only observed for negative and general symptoms, but not for positive symptoms or GAF score. As expected there was a treatment induced improvement in positive and general symptoms as well as GAF score. Likewise, patients improved on QLS, but only on SR and not in the overall measure of SPL. This may partly be because antipsychotic medication primarily improves positive symptoms, which were not correlated with QLS. Additionally, there was even a negative correlation with medication dose, indicating that patients with higher doses had the least improvement I SPL score. The results indicate that there is not a simple relationship between antipsycotic induced improvement in psychopathology and selfreported QLS. High doses of medication may even reduce QLS. Background: In recent years the goal of the treatment of patients with schizophrenia has shifted from symptom remission to the improvement in health as a whole. In this context, concepts such as quality of life (QoL), social and occupational functioning gained interest. The aim of this study is to investigate changes in QoL of chronic schizophrenia patients in the long-term follow-up and their associations with symptoms and level of community functioning. Methods: We will contact 85 patients with schizophrenia, considered clinically stable in the previous year, who participated in a study about the deficit syndrome of schizophrenia in 2009/2010. Back then, they were recruited in two sites: an outpatient service of a university general hospital (49 patients) and a community-based service (36 patients). Patients will be assessed with the same instruments adopted in the first study: SAPS, SANS, Calgary Depression Scale and Quality of Life Scale (QLS), plus the Personal and Social Performance Scale (PSP), not used at baseline. We started recruitment by the patients originally treated in the outpatient clinic.
S251. QUALITY OF LIFE OF CHRONIC
Results: Until now, of the 49 patients, 2 dropped out treatment, 8 had been transferred to other services, 5 refused to participate, 1 had the diagnostic changed to bipolar disorder and 3 had died precociously. Of the deaths, 1 was due to complications secondary to the use of clozapine, 1 due to suicide and 1 patient was murdered by another patient during a psychiatric hospitalization. Up to now, 20 patients completed reassessment, mean age at baseline was 36.9 ± 8.9 years, mean duration of mental illness was 16 ± 10.1 years, and 75% were men. They had in mean, 10.7 ± 3.3 years of education, only 4 had any work activity and 55% had a low socioeconomic position. Assessment interval was 6.9 years ± 0.5. Some demographic aspects slightly worsened: only 15% had an occupation at follow-up, and 60% fell in the lower socioeconomic position. Between assessments, 8 (40%) patients have had periods of noncompliance to medication, 5 had psychiatric hospitalizations, three of them involuntarily. At follow-up 70% of the patients were using clozapine and, despite that, some presented residual positive symptoms (SAPS 6.2 ± 4.8); Calgary mean score was low (2.2 ± 2.2) and, except for the patient who died, there was no new suicide attempts between assessments. Negative symptoms severity was moderate in general (mean SANS 14.8 ± 7.2). Patients as a group had no significant change in QLS scores (61.5 ± 28.2 versus 60.1 ± 28.2 at follow-up). However, 15% of patients had an improvement greater than 20% in their QLS scores, and 30% had a worsening of their scores greater than 20%. Baseline scores on SANS (p=0.005), SAPS (p=0.03) and number of hospitalizations (p=0.03) were negatively correlated with follow-up QLS scores; and years of schooling at baseline was positively correlated (p=0.2). Baseline QLS scores were strongly associated with current QLS scores, as well as with PSP scores (both with P <0.000) at follow-up. Regarding PSP outcomes, 50% of patients were classified in the 70-31 interval (disabilities of various degrees) and 25% were under 30, requiring intensive support.
Discussion:
The results presented are partial, obtained with a provisional small sample size. Nevertheless, they show some interesting trends as the possible existence of two patterns of outcome regarding QoL in chronic schizophrenia patients: of significant improvement and one of worsening. If those initial findings are to be confirmed, our next step will be to investigate characteristics associated to improvement or deterioration of QoL in spite of a relative stability of symptoms. That sort of information is of great relevance in the pursuit of recovery for schizophrenia patients. Background: Schizophrenia is associated with considerable health care resource utilisation (HCRU) and costs, yet little is known about the patterns of care and HRCU in patients with schizophrenia prior to diagnosis. To address this knowledge gap, we examined the HCRU of patients with and without schizophrenia over a 5-year pre-diagnosis period. Methods: This US-based retrospective study used claims data from the HealthCore Integrated Research Database to identify newly diagnosed patients with schizophrenia (ICD-9: 295.x, ICD-10: F20.x) aged 15-54 years at diagnosis. Patients with schizophrenia were compared with a demographically matched (1:4) non-schizophrenia cohort during the 0-12 months, >1-2, >2-3, >3-4 and >4-5 years prior to schizophrenia diagnosis. During the pre-diagnosis periods, both all-cause and behavioural health-related HCRU were described. Results: The schizophrenia and comparator cohorts included 6,732 and 26,928 patients, respectively. The most common types of schizophrenia were schizoaffective disorder (49%), paranoid (24%) and unspecified (19%). Patients were distributed across all major US regions (Northeast: 18%, Midwest: 27%, South: 29%, West: 27%). Average age at diagnosis was 32.8 years and most patients were male (57.4%). The percentage of patients with at least one all-cause inpatient hospitalisation in the 0-12 months
S252. HEALTH CARE RESOURCE UTILISATION IS HIGHER IN PATIENTS PRIOR TO DIAGNOSIS

